Clinical trial about influence of loxoprofen sodium on the antiplatelet effect of aspirin

Clinical trial about influence of loxoprofen sodium on the antiplatelet effect of aspirin - Interaction between aspirin and loxoprofen sodium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004475

Enrollment

Registered

2010-11-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male volunteers

Interventions

aspirin (one time a day: after breakfast) loxoprofen sodium (three times a day: after every meal) aspirin (one time a day: after breakfast) loxoprofen sodium (three times a day: after every meal) As

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy male volunteers

Exclusion criteria

Exclusion criteria: In case of corresponding to a warning in package inserts of aspirin and loxoprofen sodium. Subjects who have never taken either aspirin or NSAIDs. Subjects who have some hypersensitivities to a medicine.

Design outcomes

Primary

Measure	Time frame
Platelet aggregation activity (platelet aggregation threshold index: PATI) Serum thromboxane B2 concentration	—

Countries

Japan

Contacts

Public ContactYuuki Akagi

Tokyo University of Science Faculty of Pharmaceutical Sciences

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026